Abstract
The objective of this study was to determine the activity of daptomycin, a novel lipopeptide, against European Gram-positive isolates (n = 1539). The MIC(90)-values of daptomycin against Staphylococcus aureus isolates was 0.25 mg/L, against Enterococcus faecalis 4 mg/L, against Enterococcus faecium 8 mg/L, 0.25 mg/L against Staphylococcus epidermidis, and 0.25mg/L against Streptococcus pneumoniae. Daptomycin was equally potent against antibiotic-susceptible and resistant strains within a particular species. Based on a breakpoint of 1 mg/L for S. aureus and group A streptococci, all isolates tested were susceptible to daptomycin. Based on a breakpoint of 4 mg/L for vancomcyin-susceptible E. faecalis 99.7% of these isolates were susceptible to daptomycin.
References
Aug 1, 1987·The Journal of Antimicrobial Chemotherapy·J H AndrewD Greenwood
Jun 28, 1988·Biochemistry·J H Lakey, M Ptak
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·A LouieG L Drusano
May 17, 2001·Antimicrobial Agents and Chemotherapy·J A SilvermanT Li
Sep 28, 2001·Journal of Clinical Microbiology·A C FluitF J Schmitz
Oct 3, 2001·The Journal of Antimicrobial Chemotherapy·P C FuchsS D Brown
Oct 3, 2001·The Journal of Antimicrobial Chemotherapy·R WiseJ P Ashby
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·Ralf René ReinertRudolf Lütticken
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Peter C FuchsSteven D Brown
Mar 5, 2003·The Journal of Antimicrobial Chemotherapy·Ian A CritchleyJames A Karlowsky
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·S S RichterG V Doern
Citations
Apr 20, 2007·BMC Infectious Diseases·Helio S SaderRonald N Jones
Feb 20, 2010·Annals of Clinical Microbiology and Antimicrobials·Marylene Duah
Feb 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theodoros KelesidisDavid A Pegues
Apr 30, 2014·The Journal of Antimicrobial Chemotherapy·Ashley Hall SnyderMichael J Rybak
Sep 14, 2007·Scandinavian Journal of Infectious Diseases·Bente JørgenKjetil K Melby
Dec 17, 2008·Scandinavian Journal of Infectious Diseases·Vega A GoedeckeMarcus Hiss
Mar 17, 2007·Scandinavian Journal of Infectious Diseases·Zeina A KanafaniVance G Fowler
Nov 2, 2006·Current Medical Research and Opinion·Javier Garau
Sep 28, 2010·International Journal of Antimicrobial Agents·E BatardG Potel
Sep 9, 2008·International Journal of Antimicrobial Agents·E MalliE Petinaki
Jul 17, 2007·The Journal of Infection·David A EnochJ Andreas Karas
Jan 27, 2007·Pharmacotherapy·Richard H Drew
Apr 1, 2006·Journal of Chemotherapy·F CilliA Tunger
Dec 6, 2005·Journal of Chemotherapy·H S SaderR N Jones
Nov 20, 2014·The Journal of Antimicrobial Chemotherapy·Nicola PrincipiSusanna Esposito
Dec 3, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E Bouza
May 13, 2015·Antimicrobial Agents and Chemotherapy·Janet A HindlerRomney Humphries
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·Judith N SteenbergenFrancis P Tally
Jul 21, 2020·Journal of Medicinal Chemistry·John A KarasTony Velkov